239 related articles for article (PubMed ID: 32300592)
1.
Beach R; Abitbol JM; Allman BL; Esseltine JL; Shao Q; Laird DW
Front Cell Dev Biol; 2020; 8():215. PubMed ID: 32300592
[No Abstract] [Full Text] [Related]
2. Induction of cell death and gain-of-function properties of connexin26 mutants predict severity of skin disorders and hearing loss.
Press ER; Shao Q; Kelly JJ; Chin K; Alaga A; Laird DW
J Biol Chem; 2017 Jun; 292(23):9721-9732. PubMed ID: 28428247
[TBL] [Abstract][Full Text] [Related]
3. Mutations in the gene for connexin 26 (GJB2) that cause hearing loss have a dominant negative effect on connexin 30.
Marziano NK; Casalotti SO; Portelli AE; Becker DL; Forge A
Hum Mol Genet; 2003 Apr; 12(8):805-12. PubMed ID: 12668604
[TBL] [Abstract][Full Text] [Related]
4. A deafness mechanism of digenic Cx26 (GJB2) and Cx30 (GJB6) mutations: Reduction of endocochlear potential by impairment of heterogeneous gap junctional function in the cochlear lateral wall.
Mei L; Chen J; Zong L; Zhu Y; Liang C; Jones RO; Zhao HB
Neurobiol Dis; 2017 Dec; 108():195-203. PubMed ID: 28823936
[TBL] [Abstract][Full Text] [Related]
5. Early developmental expression of connexin26 in the cochlea contributes to its dominate functional role in the cochlear gap junctions.
Qu Y; Tang W; Zhou B; Ahmad S; Chang Q; Li X; Lin X
Biochem Biophys Res Commun; 2012 Jan; 417(1):245-50. PubMed ID: 22142852
[TBL] [Abstract][Full Text] [Related]
6. Keratitis-ichthyosis-deafness syndrome-associated Cx26 mutants produce nonfunctional gap junctions but hyperactive hemichannels when co-expressed with wild type Cx43.
García IE; Maripillán J; Jara O; Ceriani R; Palacios-Muñoz A; Ramachandran J; Olivero P; Perez-Acle T; González C; Sáez JC; Contreras JE; Martínez AD
J Invest Dermatol; 2015 May; 135(5):1338-1347. PubMed ID: 25625422
[TBL] [Abstract][Full Text] [Related]
7. Mice with conditional deletion of Cx26 exhibit no vestibular phenotype despite secondary loss of Cx30 in the vestibular end organs.
Lee MY; Takada T; Takada Y; Kappy MD; Beyer LA; Swiderski DL; Godin AL; Brewer S; King WM; Raphael Y
Hear Res; 2015 Oct; 328():102-12. PubMed ID: 26232528
[TBL] [Abstract][Full Text] [Related]
8. Cisplatin-induced ototoxicity in organotypic cochlear cultures occurs independent of gap junctional intercellular communication.
Abitbol J; Beach R; Barr K; Esseltine J; Allman B; Laird D
Cell Death Dis; 2020 May; 11(5):342. PubMed ID: 32393745
[TBL] [Abstract][Full Text] [Related]
9. Cochlear connexin 30 homomeric and heteromeric channels exhibit distinct assembly mechanisms.
Defourny J; Thelen N; Thiry M
Mech Dev; 2019 Feb; 155():8-14. PubMed ID: 30296578
[TBL] [Abstract][Full Text] [Related]
10. The inner ear contains heteromeric channels composed of cx26 and cx30 and deafness-related mutations in cx26 have a dominant negative effect on cx30.
Forge A; Marziano NK; Casalotti SO; Becker DL; Jagger D
Cell Commun Adhes; 2003; 10(4-6):341-6. PubMed ID: 14681039
[TBL] [Abstract][Full Text] [Related]
11. Gap junctions in the inner ear: comparison of distribution patterns in different vertebrates and assessement of connexin composition in mammals.
Forge A; Becker D; Casalotti S; Edwards J; Marziano N; Nevill G
J Comp Neurol; 2003 Dec; 467(2):207-31. PubMed ID: 14595769
[TBL] [Abstract][Full Text] [Related]
12. Dominant connexin26 mutants associated with human hearing loss have trans-dominant effects on connexin30.
Yum SW; Zhang J; Scherer SS
Neurobiol Dis; 2010 May; 38(2):226-36. PubMed ID: 20096356
[TBL] [Abstract][Full Text] [Related]
13.
Lucaciu SA; Figliuzzi R; Neumann R; Nazarali S; Del Sordo L; Leighton SE; Hauser A; Shao Q; Johnston D; Bai D; Laird DW
Front Cell Dev Biol; 2023; 11():1073805. PubMed ID: 36861039
[TBL] [Abstract][Full Text] [Related]
14. trans-dominant inhibition of connexin-43 by mutant connexin-26: implications for dominant connexin disorders affecting epidermal differentiation.
Rouan F; White TW; Brown N; Taylor AM; Lucke TW; Paul DL; Munro CS; Uitto J; Hodgins MB; Richard G
J Cell Sci; 2001 Jun; 114(Pt 11):2105-13. PubMed ID: 11493646
[TBL] [Abstract][Full Text] [Related]
15. Frequencies of gap- and tight-junction mutations in Turkish families with autosomal-recessive non-syndromic hearing loss.
Uyguner O; Emiroglu M; Uzumcu A; Hafiz G; Ghanbari A; Baserer N; Yuksel-Apak M; Wollnik B
Clin Genet; 2003 Jul; 64(1):65-9. PubMed ID: 12791041
[TBL] [Abstract][Full Text] [Related]
16. Timed conditional null of connexin26 in mice reveals temporary requirements of connexin26 in key cochlear developmental events before the onset of hearing.
Chang Q; Tang W; Kim Y; Lin X
Neurobiol Dis; 2015 Jan; 73():418-27. PubMed ID: 25251605
[TBL] [Abstract][Full Text] [Related]
17. Deficiency of transcription factor Brn4 disrupts cochlear gap junction plaques in a model of DFN3 non-syndromic deafness.
Kidokoro Y; Karasawa K; Minowa O; Sugitani Y; Noda T; Ikeda K; Kamiya K
PLoS One; 2014; 9(9):e108216. PubMed ID: 25259580
[TBL] [Abstract][Full Text] [Related]
18. Dominant Cx26 mutants associated with hearing loss have dominant-negative effects on wild type Cx26.
Zhang J; Scherer SS; Yum SW
Mol Cell Neurosci; 2011 Jun; 47(2):71-8. PubMed ID: 21040787
[TBL] [Abstract][Full Text] [Related]
19. Connexin26 Mutations Causing Palmoplantar Keratoderma and Deafness Interact with Connexin43, Modifying Gap Junction and Hemichannel Properties.
Shuja Z; Li L; Gupta S; Meşe G; White TW
J Invest Dermatol; 2016 Jan; 136(1):225-235. PubMed ID: 26763442
[TBL] [Abstract][Full Text] [Related]
20. Recent insights into gap junction biogenesis in the cochlea.
Defourny J; Thiry M
Dev Dyn; 2023 Feb; 252(2):239-246. PubMed ID: 36106826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
